Dr. Reddy`s Laboratories Ltd. - ADR

NYSE:RDY   4:00:00 PM EDT
73.35
+1.04 (+1.44%)
4:04:50 PM EDT: $73.35 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)12.21B
Current PE0.23
Forward PE 19.15
2yr Forward PE 18.38
See more stats
Estimates Current Quarter
Revenue$828.24 Million
Adjusted EPS$0.82
See more estimates
10-Day MA$73.56
50-Day MA$73.77
200-Day MA$68.52
See more pivots

Dr. Reddy`s Laboratories Ltd. - ADR Stock, NYSE:RDY

Door No. 8-2-337, Road No. 3, Hyderabad, Telangana 500034
India
Phone: +91.40.49002900
Number of Employees: 25863

Description

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.